Day One Biopharmaceuticals Inc

NASDAQ:DAWN   3:59:54 PM EDT
5.70
-0.05 (-0.87%)
Earnings Announcements

Day One Reports Q1 2022 Results And Provides Business Update

Published: 05/12/2022 20:48 GMT
Day One Biopharmaceuticals Inc (DAWN) - Day One Reports First Quarter 2022 Financial Results and Provides Business Update.
Day One Biopharmaceuticals Inc - Qtrly Loss per Share $0.48.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.